好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2021 Annual Meeting | C91 - Neuro-rehabilitation Update

Wednesday 04/21/21
06:00 PM - 07:00 PM EDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Carolin Dohle, MD
Dylan P. Wint, MD, FAAN
Neuro-rehabilitation
Participants should become familiar with common challenges in the care of the neurorehabilitation patient, be able to describe the therapeutic approach to the rehabilitaiton of neurological illness, understand how quality improvement in neurorehabilitation can improve care on a systems level, and become familiar with novel technologies in neurorehabilitation.
1.00 CME credit
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist
Didactic

Program Materials Program Evaluations

Event Timeline
06:00 PM - 06:50 PM EDT Speaker Neuro-rehabilitation Update
Carolin Dohle, MD, Heidi M. Schambra, MD
06:50 PM - 07:00 PM EDT Q&A Live Q&A
Carolin Dohle, MD, Heidi M. Schambra, MD
Faculty Disclosures
Dylan P. Wint, MD, FAAN Dr. Wint has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Pharmaceuticals. Dr. Wint has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Wint has received research support from National Institutes of Health (NIH). The institution of Dr. Wint has received research support from Health Resources and Services Administration (HRSA).
Heidi M. Schambra, MD Dr. Schambra has nothing to disclose.
Carolin Dohle, MD Dr. Dohle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion TPharmaceuticals. Dr. Dohle has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics.